Published in Healthcare Finance, Tax and Law Weekly, September 28th, 2005
According to recent research published in the Journal of Clinical Oncology, "Patients with cT2N0 distal rectal cancer do not require adjuvant therapy. However, when a patient refuses an APR, is there an alternative' The purpose of this trial is to determine whether preoperative external-beam radiation therapy can increase the rate of sphincter preservation for patients with distal cT2N0 adenocarcinoma of the rectum."
"Between April 1988 and October 2003, 27 patients with distal rectal adenocarcinoma staged T2 by clinical and/or endorectal ultrasound who were judged by the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.